CUBE vs LMAT · P/E 25, rev $1.07B vs P/E 35, rev $219.9M
CubeSmart (CUBE) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the CUBE and LMAT stock pages for the full models.
Not investment advice.